Vimeo
LinkedIn
Instagram
Share |

early-stage

April 13, 2023

Hanadi Jabado, managing partner at innovation investment fund Sana Capital, talks about how independent thinking and positive change is making medical advancement faster and more effective.

The traditional route from innovative ideation to hitting the market is littered with bottlenecks and bureaucracy. However, Hanadi Jabado, managing partner at innovation investment fund Sana Capital, is extolling the virtues of TechBio’s cost-and-time-cutting benefits.

Here, she talks about how independent thinking and positive change is making medical advancement faster and more effective.
 

February 16, 2023

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes. Here, she talks to Campden FB about starting the medical and cost-efficient benefits of Tech Bio and the rising importance of ‘data donation’…

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes.

A managing partner at innovation investment fund Sana Capital, Hanadi is a passionate advocate for global information sharing and firmly believes the time is now for private investment in early-stage companies that are set to positively shape the future of healthcare.

June 23, 2022

Strategic leader Hanadi Jabado talks about how her impactful investment strategy can do good and do well.

Hanadi Jabado is a passionate advocate for entrepreneurship and innovation. When she relocated to the Cambridge ecosystem, her exposure to the best of tech in Europe allowed her to develop a skill for understanding and explaining the needs of early-stage ventures. With successful investments across diverse sectors, she has since seen many startups go on to great things.

September 29, 2021

Early-stage solutions for strokes, varicose veins, surgical 3D imaging, wounds, skincare and genomic screenings are among the breakthroughs to be showcased for ambitious investors at the virtual MedTech Investing Europe Forum on 13-14 October.

Early-stage solutions for strokes, varicose veins, surgical 3D imaging, wounds, skincare and genomic screenings are among the breakthroughs to be showcased for ambitious investors at the virtual MedTech Investing Europe Forum on 13-14 October.

November 6, 2020

One of the many effects of Covid-19 has been to accelerate a lot of change that was already underway—the transition to a cashless society, for example—yet, throughout this period there has also been the growing realisation that many other aspects of our lives need updating and digitising. So, it may not be surprising to learn that at Antler, where we enable and invest in early stage startups, we have never been busier.

One of the many effects of Covid-19 has been to accelerate a lot of change that was already underway—the transition to a cashless society, for example—yet, throughout this period there has also been the growing realisation that many other aspects of our lives need updating and digitising. So, it may not be surprising to learn that at Antler, where we enable and invest in early stage startups, we have never been busier.

Click here >>
Close